BIOFILM PRODUCTION UNDER STATIC AND DYNAMIC CONDITIONS BY GENETICALLY CHARACTERIZED S. AUREUS CAUSING DAIRY COW MASTITIS. by G.G. MEDINA SNEL
 
UNIVERSITÀ DEGLI STUDI DI MILANO 
 
SCUOLA DI DOTTORATO IN SANITÀ E PRODUZIONI ANIMALI:  
SCIENZA, TECNOLOGIA E BIOTECNOLOGIE 
 
 
DIPARTIMENTO DI SCIENZE VETERINARIE E SANITÀ PUBBLICA 
 
 
CORSO DI DOTTORATO DI RICERCA IN IGIENE  
VETERINARIA E PATOLOGIA ANIMALE 
CICLO XXVI 
 
 
 
 
 
 
 
TESI DI DOTTORATO DI RICERCA 
BIOFILM PRODUCTION UNDER STATIC AND DYNAMIC  
CONDITIONS BY GENETICALLY CHARACTERIZED S. aureus 
 CAUSING DAIRY COW MASTITIS. 
 
VET05 
 
 
 
 
 
GUSTAVO GERALDO MEDINA SNEL 
 R09090 
 
 
 
 
TUTOR: PROF.SSA. RENATA PICCININI   
 
 
 
 
COORDINATORE DEL DOTTORATO: PROF. GIUSEPPE SIRONI 
 
 
 
 
A.A. 2013 
  
	  
	  
	  
 
INDEX 
 
1 Introduction……………………………………………………………………………….. 1 
1.1 Bovine mastitis…………………………………………………………………... 1 
1.1.2 Staphylococcus aureus………………………………………………… 1 
1.2 Bacterial biofilms………………………………………………………………... 4 
1.2.1 Biofilm-related infections history and the Parsek-Singh criteria….. 5 
1.3 S. aureus biofilm and bovine mastitis………………………………………….. 6 
1.3.1 S. aureus biofilm matrix components………………………………… 8 
1.4 Methods to characterize biofilm formation by S. aureus……………………... 9 
1.4.1 Genotypic characterization…………………………………………… 9 
1.4.2 Phenotypic characterization………………………………………….. 10 
2 Aims of the study………………………………………………………………………….. 13 
3 Materials and methods……………………………………………………………………. 14 
3.1 Strains……………………………………………………………………………. 14 
3.2 DNA extraction for PCR………………………………………………………... 14 
3.3 Experiment 1 – icaA/D and bap detection in Italian dairy herds…………….. 15 
3.3.1 icaA and icaD PCR……………………………………………………. 15 
3.3.2 bap PCR………………………………………………………………... 15 
3.3.3 Second sampling in one herd with bap-positive S. aureus isolates..... 16 
3.4 Experiment 2 – Biofilm characterization of S. aureus mastitis strains............ 16 
3.4.1 Congo Red agar (CRA)……………………………………………….. 16 
3.4.2 Tissue culture plate assay (TCP)……………………………………... 17 
3.4.3 Flow cell assay…………………………………………………………. 17 
3.4.3.1 Flow system assembly……………………………………….. 18 
3.4.3.2 Sterilization…………………………………………………... 19 
3.4.3.3 Inoculation and incubation…………………………………. 20 
3.4.4 DNA Microarray………………………………………………………. 21 
	  
	  
	  
3.5 Statistical analysis……………………………………………………………….. 21 
4 Results……………………………………………………………………………………… 22 
4.1 Experiment 1 – icaA/D and bap detection in Italian dairy herds…………….. 22 
4.1.1 icaA and icaD PCR……………………………………………………. 22 
4.1.2 bap PCR………………………………………………………………... 22 
4.1.3 Second sampling in one herd with bap-positive S. aureus isolates..... 23 
4.2 Experiment 2 – Biofilm characterization of S. aureus mastitis strains………. 23 
4.2.1 Congo Red agar (CRA)……………………………………………….. 23 
4.2.2 Tissue culture plate assay (TCP)……………………………………... 24 
4.2.3 Flow cell assay…………………………………………………………. 24 
4.2.3.1 TSB1%glu flow assay……………………………………….. 24 
4.2.3.2 Raw milk flow assay…………………………………………. 24 
4.2.3.3 UHT milk flow assay (MFC) ……………………………….. 25 
4.2.3.4 DNA Microarray results and correlation with biofilm  
formation on MFC…………………………………………………... 25 
5 Discussion………………………………………………………………………………….. 28 
5.1 Biofilm characterization………………………………………………………… 28 
5.1.1 CRA……………………………………………………………………. 28 
5.1.2 TCP…………………………………………………………………….. 28 
5.1.3 MFC……………………………………………………………………. 30 
5.2 Bap……………………………………………………………………………….. 34 
6 Conclusion…………………………………………………………………………………. 36 
7 References…………………………………………………………………………………. 37 
 
 
 
 
	  
	  
1	  
	  
1 Introduction 
1.1 Bovine mastitis 
Mastitis is an inflammatory process of the mammary gland. It is a physiological response to tissue 
injuries that can be caused by physical, chemical or, in most cases, infectious agents. Bovine 
mastitis is usually a result of bacterial infection: several species of both Gram positive and Gram 
negative bacteria are recognized as causative agents (Bramley et al., 1996). 
Bovine mastitis can be either clinical, when secretion abnormalities and signs of inflammation are 
clearly seen, or subclinical, with no evident clinical signs. In this case, additional laboratory 
examination of the milk need to be carried out. Typically, the diagnosis of subclinical mastitis is 
performed by bacteriologic examination and by the detection of inflammatory changes in milk, 
most represented by somatic cell counting (SCC). Cytologic and bacteriological methods are 
usually combined, since low levels of bacterial growth could occur even in samples from healthy 
glands. Subclinical mastitis is 15 to 40 times more frequent than the clinical form and it is also 
economically more important. Economical loses are associated mainly with decreased milk 
production and quality, corresponding to roughly 75% of all costs related to subclinical mastitis 
(Philpot and Nickerson, 1991).      
Staphylococcus aureus (S. aureus) is the most important causative agent of contagious mastitis, 
being widely distributed among herds all over the world (International Dairy Federation, 2006). It is 
a contagious agent, meaning that it is spread from animal to animal during milking-related 
procedures (Hermans et al. 2010).  
 
1.2 Staphylococcus aureus 
Staphylococcus aureus subsp. aureus (S. aureus) is a nonsporulating, non-motile, Gram-positive 
coccus, about 0.5-1.0 µm in diameter, that appears single, in pairs, short chains or clusters under 
microscopic examination. S. aureus cells divides in several planes to form irregular, and somewhat 
characteristic, grape-like clusters. Like other Staphylococci, members of this subspecies are 
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catalase-positive, mesophilic, facultative anaerobes, displaying a fermentative metabolism of 
carbohydrates.  
A microaerophilic variant of S. aureus, the catalase negative S. aureus subsp. anaerobius, is also  
pathogenic, sharing some virulence traits with the more common subspecies. S. aureus subsp. 
anaerobius is genetically homogeneous and causes an specific abscess disease in sheep (De la 
Fuente, Suarez, Schleifer, 1985, De la Fuente et al., 2011). Most likely, S. aureus subsp. anaerobius 
is not relevantly implicated in any other S. aureus infections in human and animal species. 
Typically, S. aureus colonies on blood agar are hemolytic, showing complete, incomplete or both 
types of hemolysis. At least four different hemolysins (α, β, δ and γ) are described in S. aureus 
(Götz, Bannerman, Schleifer, 2006), in spite of that, strains not expressing hemolytic activity are 
not so infrequent. Colonies grown under aerobic conditions are usually yellow-golden, given the 
production of the carotenoid, cell-wall associated pigment 4,4'-diaponeurosporene, also known as 
staphyloxanthin (Wieland et al., 1994). Some biochemical reactions are commonly used to 
differentiate S. aureus from other staphylococcal species: mannitol-fermentation, thermonuclease 
activity of a TNase encoded by the nuc gene and plasma coagulation by the coagulase enzyme 
encoded by the coa gene (Götz, Bannerman, Schleifer, 2006).     
The genome of S. aureus has 33% GC content and is 2.8 Mb long, consisting of a conserved core 
and highly variable regions. These variable regions are constituted of genetic elements such as 
genome islands, integrated prophages, insertion sequences (IS), composite transposons, and 
integrated plasmids. These elements correspond to less than 10% of the genome, but contribute 
significatively to strain virulence (Gill et al., 2005). Transposons, bacteriophages and plasmids are 
genetic mobile elements, thus capable to promote horizontal transfer of virulence genes 
(Malachowa and DeLeo, 2010). 
Besides its known role in bovine mastitis, S. aureus is the agent of a vast array of infections in 
several mammal species and birds. It is recognized as one of the most important infectious agents in 
human medicine, given the growing spread of multi-resistant strains in both hospitals and 
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community. Antimicrobial multi-resistance is not of great concern in bovine mastitis, since 
multiresistant strains are sporadically isolated and generally do not belong to the most virulent 
human biotypes (Botrel et al., 2010).  
S. aureus virulence factors can be separated in extracellular products and cell-wall associated 
components. Extracellular products are mainly enzymes or highly-immunogenic proteins. Some 
examples of important extracellular virulence factors are: hemolysins, leucocidins (PVL, LukM), 
coagulase, enzymes that cleave antimicrobials (β-Lactamases), proteases (SspA, SspB and Aur) and 
superantigens (TSST-1 and SEA). Enterotoxins are a large family of staphylococcal superantigens 
responsible of a representative percentage of human cases of food poisoning. These molecules 
stimulate the immune system eliciting a massive specific, intestinal T-cell response, resulting in 
diarrhea. Enterotoxin-forming ability highlights the great importance of S. aureus in food 
microbiology and animal production, since food products of animal origin are frequently involved 
in staphylococcal food poisoning (Madigan et al., 2009).   
Cell wall associated components playing a role as virulence factors are mostly surface proteins. Out 
of them, Penicillin-binding protein (PBP), protein A and Microbial Surface Components 
Recognizing Adhesive Matrix Molecules (MSCRAMMs) are probably the most studied. PBP  
prevents β-lactams action on the wall, thus conferring antibiotic resistance. Protein A inhibits 
opsonophagocytosis, binding the constant domain of IgG antibodies (Smith et al, 2011). 
MSCRAMMs are a group of adhesins targeting surface components of the host cells, promoting 
adhesion (Foster and Hook, 1998). The capsular polysaccharide (CP) is also a crucial surface-
associated virulence factor. S. aureus strains show different capsular polysaccharide types, which 
classically are defined by agglutination with specific sera. Currently, 11 serotypes of capsular 
polysaccharides are partially or completely chemically characterized. Neverthless, some strains 
express nontypeable capsular types. Capsular polysaccharides can differ in some biological 
properties but, in general terms, help colonization and persistence by surface adhesion mechanisms 
and the impairment of phagocytosis (O’Riordan and Lee, 2004).        
	  
	  
4	  
	  
During the course of infection, S. aureus can be intermittently shed in milk, making its bacteriologic 
detection difficult. Also, depending on the strain, SCC do not always show high values (Pilla et al, 
2012). Therefore, the detection of infected animals is not so easily accomplished, especially if the 
analysis is performed only on a single milk sample over time (Schroder and Hamann, 2005). The 
delay or failure in detecting infections is troublesome during control programs, because they are 
based on segregation, treatment and culling of S. aureus infected animals (Piccinini, Borromeo, 
Zecconi, 2010). 
 
1.2 Bacterial biofilms 
Biofilm was defined as “a structured community of cells enclosed in a self-produced, hydrated, 
polymeric matrix adherent to an inert or living surface” (Costerton, Stewart, Greenberg, 1999). 
Observations of environmental microorganisms showed that biofilm formation is considered more a 
rule than an exception in bacterial way of life. In the past 30 years, a crescent number of reports of 
biofilm related infections demonstrated that the same is probably true for pathogenic bacteria. 
Costerton Stewart and Greenberg (1999) estimated that 65-80% of all human bacterial infections 
are related to biofilm formation in some extent.  
Biofilm formation occurs in a two step process: an attachment phase and an accumulation phase. 
The initial attachment is a reversible phase, with bacterial cells, usually single plaktonic cells, 
adhering to the surface to be colonized. Then an irreversible point is reached and the first step ends. 
What follows is the accumulation of extracellular polymeric substances (EPS), or matrix, as well as 
bacterial multiplication. The resulting multi-layered, matrix embedded structure, presents with a 
complex architecture. De-attachment and fluid carriage of single cells or clumps from this structure 
allow the colonization of substrates far from the original biofilm. Bacterial cells within the layers 
display significant differences in metabolic rates. Such characteristic, together with the physical 
protection conferred by the matrix, make biofilms intrinsically resistant to antimicrobial therapy and 
the immune response (Costerton, 2007, Hoiby et al., 2010).  
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Device (foreign-body)-related infections are well-known examples of biofilm infections. S. aureus 
and S. epidermidis are among the most prevalent etiological agents. These organisms originate from 
skin and nares of the patient, where they are present as commensals, or from other sources like 
healthcare workers and water (Donlan, 2011). Despite their evident epidemiological importance, 
these infections are not representative of the whole range of biofilm infections. When biofilms start 
developing directly on the affected tissue, infections are far more complex, with still several 
knowledge gaps needing to be filled.  
 
1.2.1 Biofilm-related infections history and the Parsek-Singh criteria 
The early years of the studies of biofilm-related infections have been hampered by problems with 
terminology and the unavailability of sensitive methods for matrix chemical characterization. The 
term “slime” was used denoting capsular polysaccharide, capsule, matrix or even biofilm itself. The 
use of this term was intended to imply the non-rigid nature of the substance surrounding the bacteria 
(Flemming and Wingender, 2010). Neverthless, “biofilm” and “slime” are not interchangeable 
terms (Deighton, Borland, Capstick, 1996) and the use of more specific terms should be preferred 
when referring to biopolymers.      
The lack of standard guidelines was an additional difficulty in the diagnosis of biofilm-related 
infections. The Parsek-Singh criteria (Parsek, Singh, 2003), a currently accepted principle, 
establishes four basic postulates aimed to help the identification of such infections. The original 
concept was recently expanded by Hall-Stoodley and Stoodley (2009). According to this updated 
Parsek-Singh criteria, biofilm mediated infections are:  
(1) associated to tissue surfaces,    
(2) present with microbial aggregates at the site of infection usually with evident, abundant EPS,  
(3) confined to a particular host site;  
(4) resistant to antibiotic treatment despite the demonstrated susceptibility of planktonic bacteria in 
vitro;  
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(5) frequently present with culture-negative results, in spite of clinically documented suspicion of 
infection; 
(6) characterized by evidence of ineffective immune clearance, as indicated by the observation of 
microbial aggregates together with host inflammatory cells.  
These criteria are relatively fulfilled in several human infections caused by S. aureus, like chronic 
wounds, urinary tract and cystic fibrosis associated infections (Hall-Stoodley and Stoodley, 2009).  
 
1.3 S. aureus biofilm and bovine mastitis 
S. aureus subclinical mastitis is often associated with chonicity/persistence and therapeutic failure 
when compared to other agents (Ikawati, 2010). Currently, two theories, based on the characteristics 
of the agent, try to explain this phenomenon. The first theory is based on S. aureus facultative 
intracellular location, the other one on biofilm formation inside the mammary gland. S. aureus 
ability to invade epithelial mammary cells and phagocytes was demonstrated by Almeida et al. 
(1996), Bayles et al. (1998) and Hébert et al. (2000). Intracellular survival is strain-dependent and 
some lineages are more adapted to mammary niche. Bovine strains harboring allele I of the 
accessory gene regulator (agrI) invaded cultivated cells more effectively when compared with agrII 
strains (Buzzola et al., 2007). However, both agrI and agrII strains are known to cause bovine 
mastitis (Schlotter et al., 2012) but no correlation between agr type and chronicity is found in the 
literature. Cellular invasion is poorly documented in vivo (Dego, van Dijk, Nederbragt, 2002) and it 
seems logic that intracellular maintenance and subsequent spreading should occur, in order to 
reactivate the infection. Nevertheless, there is still a lack of clear evidences of these processes 
taking place in vivo.  
The hypothesis of biofilm-formation as a cause of bovine mastitis is widely accepted. The low 
therapy success rate, despite the demonstration of in vitro antimicrobial susceptibility of mastitis 
isolates, is the most important epidemiological evidence of biofilm implication (Melchior, 
Vaarkamp, Fink-Gremmels, 2006). Studies where S. aureus biofilms were developed in vitro, 
	  
	  
7	  
	  
showed that biofilm forms are, in general, more resistant when compared to their planktonic 
counterparts (Amorena, et al., 1999, Melchior, Fink-Gremels, Gaastra, 2007). Also, strains isolated 
from milk more likely formed biofilms when compared to isolates from extramammary sources 
(Fox, Zadoks, Gaskins, 2005). Nevertheless, both intracellular survival and biofilm formation are 
strongly strain-dependent and are apparently not necessarily each other related (Oliveira et al., 
2011).  
Other aspects of bovine mastitis caused by S. aureus do not fit so well in Singh-Parsek criteria. Data 
by both in vitro and in vivo observations do indicate that staphylococcal adhesion to epithelial cell 
surface is a prerequisite for the establishment of infection (Almeida et al., 1996, Hensen et al., 
2000). However, bacterial biomass in affected mammary glands is barely detectable. Previous 
studies evidenced small numbers of bacteria in tissue in comparison with those found in milk 
(Hensen et al, 2000, Piccinini et al., 2012). Surely these observations can be affected by the 
inadequacy of slide preparation techniques, given the complex structure of the gland and the 
presence of milk, which is troublesome for most histopathologic techniques (Gudding, McDonald, 
Cheville, 1984). Hensen et al. (2000) demonstrated the presence of bacterial aggregates near the 
epithelial inner-surface of experimentally infected glands. The relative small size of these clumps 
(“more than 30 cells”) and the lack of evident extracellular matrix around them, make it difficult to 
differentiate staphylococcal multiplication from biofilm formation. In the same study, the authors 
also observed a variable presence of inflammatory cells in the early stages of infection, with few S. 
aureus cells associated with the epithelium and the adjacent interstitial tissue. In the chronic stage, 
clusters of bacteria were clearly associated with inflammatory cells, but intracellular location and 
deeper infiltrations occurred as well and in larger extent when compared to early stages (Hensen et 
al., 2000).  
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1.3.1 S. aureus biofilm matrix components   
Important components in S. aureus biofilm formation are: cell-wall associated adhesins (most 
importantly MSCRAMMs), teichoic acid, extracellular DNA (ecDNA) and the exopolysaccharide 
poly-N-acetylglucosamine (PNAG) (Otto, 2008). MSCRAMMs are very important in the initial 
attachment of bacteria for biofilm formation. Natural variability and functional redundancy of these 
proteins occur among strains (O’Riordan and Lee, 2004), while PNAG, teichoic acid and ecDNA 
are more likely to be constitutively expressed. Rarely, MSCRAMMs can promote biofilm 
accumulation even in the absence of PNAG-mediated mechanisms (O’Neill et al, 2008). 
Staphylococcal teichoic acids are highly negatively charged polymers linked to peptidoglycan (cell 
wall teichoic acids)  or the cytoplasmic membrane (lipoteichoic acids) (Götz, Bannerman, Schleifer, 
2006). Bound teichoic acids are, in great part, responsible for the initial adhesion step through 
physicochemical interaction with surfaces (Gross et al., 2001). As showed in a strong biofilm 
producer S. aureus strains, fractions of teichoic acids can also be released from the cell wall. These 
extracellular teichoic acids form non-covalent complexes with other components of the extracellular 
matrix, thus participating in biofilm accumulation (Vinogradov et al., 2006).      
The enzyme N-acetyl-glucosaminyl-transferase, is encoded by the icaADBC operon, and is 
responsible for the synthesis of PNAG. PNAG is more relevant in the accumulation phase and is by 
far the most studied matrix component of staphylococcal biofilms. Initially described in S. 
epidermidis biofilms, PNAG usually corresponds to 50% or more of the biofilm matrix in this 
species. To the contrary, in S. aureus biofilms, PNAG is not so abundant, changing the relative 
importance of other matrix constituents. The diversity in matrix composition is largely strain-
dependent, evidences indicate that ecDNA is probably the main accumulation component in this 
species  (Izano et al, 2008).      
The characterization of biofilm-associated protein (Bap) in S. aureus allowed the discovery of a 
new group of proteins related to biofilm formation in several infectious bacteria, including Gram 
negative species (Lasa and Penades, 2006). The first description of Bap was made by Cucarella et 
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al. (2001) in a small proportion of bovine subclinical mastitis S. aureus isolates in Spain. 
Thereafter, no Bap-positive S. aureus was found, either of human origin or of animal species. 
(Vautor et al., 2008). On the other hand, Bap proved to be highly prevalent in coagulase negative 
staphylococcal species. Bap is a large cell-wall-anchored protein that mediates both initial surface 
adhesion and biofilm accumulation. In fact, it was demonstrated that Bap-positive mutants, lacking 
the ica locus, are still able to form biofilm in vitro (Cucarella et al., 2001).  
In the bovine host, S. aureus Bap-positive strains were more able to colonize and persist in the 
mammary gland (Cucarella et al., 2004) even though, Bap expression seems to be strongly down-
regulated or blocked in Calcium rich substrates as milk (Arrizubieta et al., 2004). Despite the host-
specificity of Bap-positive S. aureus strains, the gene bap is located in a mobile pathogenicity 
island (SaPIbov2) and thus capable of horizontal transfer. This transfer would be possible only 
among S. aureus strains, since in other staphylococcal species, bap gene is not carried in mobile 
genetic elements (Tormo et al, 2005).    
 
1.4 Methods to characterize biofilm formation by S. aureus 
Characterizing the biofilm-forming ability of S. aureus isolates is essential to improve the 
knowledge on the mechanisms influencing this trait. Growth conditions can substantially change the 
expression of S. aureus biofilms. The ability to adhere to different surfaces is variable among 
strains and also the response to different media components (Rode et al, 2007). Molecular and 
phenotypic methods are available to characterize the biofilm-forming ability and the best results are 
reached by the combination of both methods (Vasudevan et al, 2003).   
 
1.4.1 Genotypic characterization     
The PCR detection of the ica operon in S. epidermidis from device-related infections was initially 
conceived to help the identification of clinically-relevant isolates. This approach proved to be useful 
in the diagnosis of CNS infections (Arciola, Baldassari, Montanaro, 2001) and a good correlation 
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was expected also in infections caused by  S. aureus. To the contrary, in this bacterial species the 
presence of ica was not sufficient to determine biofilm formation, since ica is detected in the 
majority of S. aureus isolates (Rohde et al., 2001). Moreover, other genes of biofilm-associated 
components (e.g.: MSCRAMMs, capsular polysaccharide) act in similar way. The presence of 
genetic markers seems an inefficient way to characterize biofilm formation, since genetic profile 
only corresponds to the biofilm-forming potential. Therefore, gene expression seems to be the key 
factor determining biofilm formation. Gene expression of biofilm components is controlled by 
complex regulatory systems. Environmental triggers, nutrient availability, temperature, osmolarity 
and cell density activate or block systems that coordinate genes encoding biofilm components and 
enzymes catalyzing the process. Examples of regulatory systems implicated in S. aureus biofilm 
formation are sigB, the quorum-sensing system encoded by the accessory gene regulator (agr) and 
sarA (Rachid et al., 2000, Vuong et al., 2000, Beenken, Blevins, Smeltzer, 2009). Regulation occurs 
in other points beyond the establishment of biofilm. Biofilm maturation and the de-attachment of 
cells is controlled by the late expression of proteases, modulation of endonuclease activity and 
autolysis mechanisms (Lauderdale et al, 2009).          
 
1.4.2 Phenotypic characterization  
The first implemented and diffused method for biofilm characterization was the tube method also 
known as Christensen’s method. This semi-quantitative test is based on the staining of biofilm 
adherent to the walls of a glass tube after overnight incubation in liquid media without shaking 
(Christensen et al., 1982).  
The Congo Red Agar (CRA) is also a qualitative characterization method, proposed as an 
alternative to the tube test. The medium was developed to detect slime-forming strains of S. 
epidermidis, that appear as black-rough colonies in contrast to red-smooth colonies of slime-
negative strains. Despite the problems regarding the definition of “slime”, as mentioned before, 
CRA has obvious advantages, since it is easy to perform and more reproducible, when compared to 
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the tube test (Freeman, Falkiner, Keane, 1989). Presumably, only clinically significant isolates from 
catheter infections would form slime on CRA (Arciola et al., 2002). Since S. aureus is also an 
important catheter-related infection agent, the method was soon adapted to screen slime-production 
in this species as well. Only a small correlation (3.8%) between CRA and a quantitave methods was 
observed by Knobloch et al. (2002), indicating that the test is not adequate for biofilm 
characterization of S. aureus strains from human infections. Characterization of bovine mastitis 
strains using CRA showed variable results as well as concordance with other methods described in 
the available literature (Vasudevan et al., 2003, Oliveira et al., 2006, Delgado et al., 2011).     
The microtiter plate test, also developed by Christensen et al. (1985), is based on the same principle 
of the tube test, but plastic (polystyrene) multi-well plates are used for biofilm development and the 
stained biomass is measured by spectrophotometry, rendering it quantitative. The test was originally 
designed to characterize S. epidermidis biofilms, but was later adapted to several other bacterial and 
yeast species. Variations of this method are currently the most used tests to measure biofilm-
formation. The advantages of this type of characterization method is its low cost, the possibility to 
screen several strains and to set different conditions in the same microtiter plate (Coenye and Nelis, 
2010). Following the recommendations of Kennedy and O’Gara (2004), only hydrophilic, 
negatively charged polystyrene should be used to test S. aureus strains, given the physical-chemical 
properties of its cell wall. These characteristics are commonly found in tissue culture treated plates 
and for that reason some authors refer to this test as tissue culture plate method or TCP (Vasudevan 
et al., 2003, Dhanawade et al., 2009).  
Currently, more refined biofilm characterization methods are based on dynamic systems. The 
general principle of dynamic systems is to allow biofilm formation inside chambers fed with 
medium flow (flow chambers or flow cells). The constant medium flow circunvents the interference 
of accumulated signaling molecules and metabolic residues, which occurs in static/closed systems, 
like the microtiter plate test (Coenye and Nelis, 2010). The flow itself is an important factor for 
biofilm formation: fluid shear forces induce rolling migration of bacterial aggregates and trigger 
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stronger adhesion to the surfaces (Rupp, Fux, Stoodley, 2005). These methods represent a more 
realistic approach, emulating some basic aspects of the environments where biofilms occur. 
Disadvantages are that these systems are expensive, time consuming and do not allow a large 
number of samples to be characterized simultaneously. 
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2 Aims of the study 
Biofilm formation has been pointed out as an important factor in the establishment of S. aureus 
bovine mastitis, particularly in its chronic form. Most authors used static systems and matrices other 
than milk to characterize biofilm formation by strains isolated from bovine mastitis. Since in vitro 
biofilm formation can be highly affected by medium composition and experimental conditions, 
characterization results obtained in static systems using broth are probably not adequate to access 
the potential of this bacterial trait in mastitis. The objectives of the study were: (1) to investigate the 
occurrence of ica and/or bap-positive S. aureus strains in Italian herds; (2) to characterize biofilm of 
bovine mastitis isolates using a standard static method and to compare the results with a flow based 
assay  (3) to look for genetic markers to identify strains capable of biofilm formation in a dynamic 
system. 
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3 Materials and methods 
3.1 Strains 
Bacterial isolates have been collected from quarter milk samples of dairy cow mastitis in 85 
different Italian herds, which were participating in a control program for contagious pathogens. 
Quarter milk (10 µL) was plated on blood agar plate (5% bovine blood; Oxoid, Cambridge, UK) 
and incubated overnight at 37 °C. Milk somatic cells (SCC) of all samples were counted on a 
Bentley Somacount 150 (Bentley Instruments, Chaska MN, USA) and recorded. Colonies of growth 
were isolated and identified as S. aureus by cultural and biochemical tests (Hogan et al., 1999). A 
real time PCR, targeting constitutive genes nuc and Sa442 (Pilla et al., 2012), was carried out to 
confirm the initial identification. Strains were maintained at −80 °C in Microbank Bacterial 
Preservation System (Thermo Fisher Scientific Inc., Waltham MA, USA). Overall 112 S. aureus 
strains were tested in the present study. One strain per herd was selected, except when 
phenotypically different S. aureus isolates were found in the same herd. In these cases, additional 
strains representing each phenotype were also selected.  
 
3.2 DNA extraction for PCR 
S. aureus strains were thawed, plated onto blood agar plates (5% bovine blood; Oxoid), incubated 
for 24h at 37o C and checked for purity. Three colonies were suspended in 500 µL of PCR-grade 
water (GIBCO, Grand Island, NY, USA) and homogenized by vortexing for ten seconds. Bacterial 
genomic DNA was extracted using a commercial kit (QIAamp DNA mini kit QIAGEN, USA) 
following the manufacturer’s instructions with the addition of lysostaphin (5mg/mL; Sigma-
Aldrich, MO, USA) to enhance bacterial lysis. DNA amount and purity were checked with a ND-
100 Spectrophotometer (NanoDrop Technologies Inc., Wilmington, DE, USA). Extracted DNA was 
used in the following reactions: real time PCR for the detection of nuc and Sa422; conventional 
PCR for the detection of bap, icaA and icaD. 
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3.3 Experiment 1 – bap detection in Italian dairy herds 
3.3.1 icaA and icaD PCR 
The protocols to amplify icaA and icaD were those described by Arciola , Baldassari, Montanaro, 
(2001) with minor modifications. The reactions were performed in 25 µL volumes containing 1 µM 
of each primer, 10mM buffer, 2.5 mM MgCl2, 100 µM of each deoxynucleoside triphosphates, 1.5 
U of Taq DNA polymerase (Promega, USA) and approximately 50 ng of DNA template. The same 
thermal cycle was used for both icaA and icaD amplifications with the following steps: initial 
denaturation at 94oC for 2 min, followed by 50 cycles at 94o C for 15 s, 49o C for 20 s and 72o C for 
15 s, with a final extension step at 72o C for 2 min. PCR products were analysed by electrophoresis 
on 1.5% agarose gel containing 0.5 µg/mL ethidium bromide in TAE buffer (Sigma, USA). 
Amplification bands were visualized on an UV transilluminator. Expected product sizes were 188 
bp and 198 bp, respectively. 
 
3.3.2 bap PCR 
PCR to detect bap was performed using primers and conditions described by Cucarella et al. (2004) 
with minor modifications. Briefly, each 25 µL amplification reaction mixture contained 5 µM of 
each primer (Fw sasp-6m: 5′ CCCTATATCGAAGGTGTAGAATTGCAC 3′, Rw sasp-7c: 5′ 
GCTGTTGAAGTTAATACTGTACCTGC 3′), 200 mM deoxynucleoside triphosphates (dNTPs), 
Green GoTaq Flexi Buffer (Promega, WI, USA), 2 mM MgCl2, 1 U of GoTaq DNA polymerase 
(Promega, WI, USA) and approximately 50 ng of DNA template.  The thermal protocol consisted of 
an initial step at 94° C for 2 min, followed by 40 cycles including 94° C for 20 s, 50° C for 20 s and 
72° C for 50 s, with a final extension at 72° C for 5 min. Expected amplicon size was 971 bp. PCR 
products were analyzed by electrophoresis on 0.8% agarose gel containing ethidium bromide (0.5 
µg/mL) in TAE buffer. As positive or negative controls, one S. aureus bap-positive reference strain 
(strain V329, kindly provided by Dr. José Penadés) and one S. aureus bap-negative strain (ATCC 
23213) were used. PCR products, compatible with the expected bap amplicon, were excised from 
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the gel, purified with a commercial kit (Wizard SV Gel and PCR Clean-Up System, Promega, 
USA) and submitted to sequencing in an external facility laboratory. 
 
3.3.3 Second sampling in one herd with bap-positive S. aureus isolates 
Further bacteriological analyses of milk were performed, six months apart from the original 
screening, in one herd with a bap-positive S. aureus isolate. Quarter milk samples were collected 
from all lactating cows (n = 182) check the frequency of bap-positive strains.   
 
3.4 Experiment 2 – Biofilm characterization of S. aureus mastitis strains 
3.4.1 Congo Red agar (CRA) 
Twenty six S. aureus isolates were randomly selected to be tested by Congo Red Agar (CRA) 
method. A Staphylococcus pseudintermedius from bovine mastitis was also tested. Such isolate had 
been genetically characterized by rpoB gene sequencing according to Drancourt and Raoult (2002), 
Three reference strains were also tested: S. aureus ATCC23213, S. aureus ATCC25923, and S. 
epidermidis ATCC12128. All strains were inoculated in BHI broth (Oxoid, UK) and incubated at 
37o C overnight. Bacterial cultures were then vortexed, diluted 1:250 in sterile physiological saline 
and plated onto Congo Red Agar plates. Colonies were checked for colour and surface texture after 
24 h incubation at 37o C and after additional 48 h at room temperature (Arciola et al., 2002). 
Black/rough colonies were considered as slime producing, while red/smooth colonies were 
considered as slime negative. Combinations of black/smooth, brown/smooth, bordeaux/smooth, 
red/rough or black/rough colonies with red centres were classified as undetermined. Two different 
CRA batches were used to test the reproducibility of medium preparation. The test was repeated 
three times on different days.  
 
 
 
	  
	  
17	  
	  
3.4.2 Tissue culture plate assay (TCP) 
Overnight TSB cultures were vortexed, diluted 1:40 in Tryptic Soy Broth (Oxoid, UK) 
supplemented with 0.75% Glucose (TSBglu1%) and inoculated (200 µL per well), in triplicate, in a 
96 well flat bottom polystyrene tissue culture plate (Life Technologies, USA). After 18-hour 
incubation at 37o C in a humid chamber, well content was removed by carefully inverting and 
tapping the plate. Wells were washed with 250 µL of PBS and then with 250 µL  of distilled water. 
The plate was inverted and air dried at room temperature. The wells were stained with 0.1% 
Safranin for 5 min, the dye was poured off and the excess was removed by washing twice with 
distilled water, then the plate was inverted onto clean absorbent paper and air dried. Finally, 200 µL 
of acid alcohol (ethanol absolute/12mM hydrochloric acid) was added to each well and the optical 
density was measured at 492 nm (OD492nm) on a spectrophotometer (Spectramax, Molecular 
Devices, USA). Three uninoculated wells containing TSBglu1% served as blank. To each plate, a 
positive (S. aureus ATCC 25923) and a negative control (ica-negative strain S. aureus MB543) 
were also added in triplicate. All strains were tested three times on different days. The cut-off value 
to discriminate biofilm-forming from non biofilm-forming strains was defined using the classical 
method described by Christensen et al. (1985) and by Cluster analysis.  
 
3.4.3 Flow cell assay  
A qualitative flow cell assay, based on the gravimetric system described by Bos et al. (1994), was 
used to characterize the biofilm formation, mimicking basic intramammary environment conditions. 
A simplified scheme of our “once through” flow system is depicted in Fig. 1. To ensure that the 
flow system would allow biofilm formation without interfering with the process, the flow system 
was initially tested using TBSglu1% as culture medium. 2, 3, 5-Triphenyl Tetrazolium Chloride 
(TTC, Sigma, D) was added to a final concentrarion of 0.05% (w/v), to facilitate biofilm 
visualization. TTC was used as a cellular marker, since its reduced form, formazan, accumulates 
only inside metabolic active cells. Such procedure avoids the manipulation of the delicate, recently 
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formed biofilms for staining purposes. As controls, four TCP tested strains, were selected: two 
negatives, one positive and one strong positive. Thereafter, UHT milk was used as culture media. 
All strains tested by the dynamic system were previously checked for their ability to reduce 
colourless TTC to red formazan in both TSB and milk. Finally, 30 strains out of 112 tested by TCP 
method, were chosen to be characterized by a flow system using UHT milk with TTC as substrate 
(MFC method). Each strain was characterized by a different level of biofilm formation, accordingly 
to OD492nm values. Both TCP controls were also tested by MFC.  
 
 
Fig. 1: schematic representation of the flow system for biofilm characterization 
 
3.4.3.1 Flow system assembly 
The general system consisted of a drilled polycarbonate flow cell with two grooves (65 x 5 x 4 mm, 
volume: 1.3 mL each) fed by an intravenous infusion bag (Galenica Senese, Italy). The flow cell 
was custom-manufactured following the design recommendations of Palmer et al. (2006). A cell 
culture-treated slide (Sarstedt, Germany) was fixed onto the chamber using silicone sealant to close 
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the flow cell. Flow velocity was set using a sterile flow regulator line (Ferrari, Italy) and all 
remaining connections were made with 5 mm internal diameter silicone tubes.  
 
3.4.3.2 Sterilization 
The system was sterilized using 200 mL of a freshly prepared 0.5% sodium hypochlorite solution 
flowing through the system for 4 h. The lines were then emptied and washed two times with 100 
mL of sterile distilled water to remove any hypochlorite residue. The flow cell was then briefly 
washed with the medium and both the inlet and outlet tubing were clamped with haemostatic 
forceps.  
 
3.4.3.3 Inoculation and incubation 
Inoculum concentration was determined by spectrophotometric analysis (OD600nm) of bacterial 
suspensions, using a Spectramax instrument (Molecular Devices, USA), followed by standard 
colony counting on plate count agar (Oxoid, UK).  
After removal of the outlet clamping, approximately 1.0 x 107 S. aureus CFU was injected directly 
inside the medium filled channel through the inlet tube, using sterile needle and syringe (Terumo 
Corp., UK). The outlet tube was once again clamped and the flow cell was incubated at 37o C with 
the polystyrene slide facing downward to permit bacterial adhesion. After 1 h, the chamber was 
turned upward and the medium flow was initiated and maintained at 30 mL/h for 18 h. Aliquots (25 
µL) of both inlet and outlet medium were plated onto 5% bovine blood agar plates (Oxoid, UK) and 
incubated overnight at 37°C, to check medium sterility and strain purity. Finally, the system was 
washed with 30 mL of sterile distilled water for 1 h, to remove any residual unbound bacteria. 
Strains were considered as biofilm-positive when a red-stained layer of bacterial growth was clearly 
visible along the slide surface inside the chamber (Fig. 2).  
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Slides were also observed under light microscopy with 1000x magnification and classified as 
follows: positive, in the presence of multilayered cell growth and abundant extracellular matrix, or 
negative, when rare cocci or small clusters were  attached in monolayer (Fig. 3).  
 
 
Fig. 2: macroscopic appearance of MFC flow chambers, A) non-biofilm forming 
strain, B and C) biofilm-forming strains.  
 
 
 
Fig. 3: microscopic inspection of MFC slides (1000x), A) non-biofilm forming 
strain, B) biofilm-forming strain.  
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3.4.4 DNA Microarray 
All MFC-tested strains were genetically characterized using a DNA microarray, which detects a 
total of 329 different sequences, including accessory gene regulator (agr) alleles, genes coding for 
virulence factors (toxins, enterotoxins, putative toxins, haemolysins, proteases, and biofilm 
formation factors) and microbial surface components recognizing adhesive matrix molecules 
(MSCRAMMs), capsule type-specific genes, and numerous antimicrobial resistance genes 
(Supplementary table 1). The genotyping service was performed at Alere Technologies (Jena, 
Germany). 
 
3.5 Statistical analysis 
All statistical analyses were performed using SPSS Statistics 17.0 software (SPSS Inc., USA). 
The determination of the cut-off value for the classification of the strains tested as biofilm-forming 
or non-biofilm forming in TCP assay, was performed by Cluster Analysis using Ward’s hierarchical 
method. The optimal number of categories was defined following the considerations of Hair et al. 
(2009) for aggregative processes. 
The association between the ability to form biofilm in the flow model and the strain genetic 
characteristics was analyzed by means of multiple regression analysis. 
The agreement between TCP and MFC results was estimated by Cohen's kappa test for binary 
variables. 
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4 Results 
4.1 Experiment 1 – icaA/D and bap detection in Italian dairy herds 
4.1.1 icaA and icaD PCR 
Out of 112 strains tested by PCR, 73 (65.18%) carried icaA and icaD, 2 (1.79%) only icaA, 15 
(13.39%) only icaD and 22 (19.64%) were negative for both genes. 
 
4.1.2 bap PCR 
In seven (6.25%) S. aureus strains, out of 112 tested, a fragment compatible with bap was 
amplified; amplicons were further analysed by sequencing and confirmed as the constant part of 
bap gene. The result showed 98% to 99% homology with the reference bap gene (NCBI accession 
AY220730.1) using Genbank BLAST® analysis (http://blast.ncbi.nlm.nih.gov/). The strains were 
from four herds located in different Italian regions. In three herds (A, B and D), additional bap-
negative S. aureus strains were also isolated. Overall, milk samples infected by bap-positive strains 
showed lower SCC and higher bacterial counts, when compared to the other milk samples (Table 
1). Phenotypically, all strains produced macroscopically visible clumps in broth culture (Fig. 4), 
similarly to what observed with the bap-positive control strain S. aureus V329. Also, all strains 
showed a strong biofilm formation in the tissue culture plate assay, with higher OD492nm values than 
the positive control S. aureus ATCC 25923 (data not shown).  
 
 
Bap-positive strains Bap-negative strains 
Herd SCC/mL 
S. aureus count 
(UFC/mL) 
SCC/mL 
S. aureus count 
(UFC/mL) 
A 3x105 > 2.000 6.8x105 < 400 
B 1x106 > 2.000 2x106 < 400 
D 1.3x105 >2000 5.7x105 <400 
 
Table 1. Milk somatic cell and bacterial counts in milk samples from herd A, B and D 
where bap-positive and bap-negative strains were detected. 
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4.1.3 Second sampling in one herd with bap-positive S. aureus isolates 
S. aureus was isolated from 31 quarter milk samples from 23 animals in the second sampling in 
herd B. Differently from the previous sampling, only bap-positive S. aureus were isolated. S. 
aureus counts in milk were higher than 2.0 x 103 CFU/mL in 70% of samples. Following the SCC 
categorization scheme proposed by Cucarella et al. (2004), 48% of samples SCC were classified as 
very low (<2.0 x 105 cells/mL), and in 22% as medium-low (2.0 x 105 - 7.5 x 105 cells/mL). 
 
 
Fig. 4: Presence of clumps in broth culture of a bap positive strain (B) and absence in a 
bap negative strain. 
 
4.2 Experiment 2 – Biofilm characterization of S. aureus mastitis strains 
4.2.1 Congo Red agar (CRA) 
Out of 27 mastitis isolates tested, 6 (22.2%) grew as black/rough colonies (“slime-producing”) and 
20 (74%) were classified as undetermined. S. aureus reference strain ATCC 25923 displayed classic 
“slime-producing” black/rough colonies while S. aureus ATCC 23213 displayed black/smooth 
colonies and S. epidermidis ATCC12128 bordeaux/smooth colonies, therefore were classified as 
undetermined. The aspect of isolated colonies was very conserved, no differences were observed 
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between repetitions and medium batch. S. pseudintermedius was the single strain showing 
red/smooth colonies.     
 
4.2.2 Tissue culture plate assay (TCP) 
The results of TCP assay were analysed by cluster analysis. The data were naturally grouped in two 
clusters with an optimal OD492nm cut-off value of 0.95: cluster one comprised the negative control 
and samples with low OD492nm values (mean 0.40; SD 0.27) while cluster two grouped the positive 
control and samples with high OD492nm values (mean 1.75; SD 0.52). Therefore, 88 (78.57%) strains 
with an OD492nm value lower than 0.95 were classified as non-biofilm forming while 24 (21.43%) 
with OD492nm higher than 0.95 were considered as biofilm forming.  
According to the classification proposed by Christensen et al (1985), 85 (75.89%) out of 112 strains 
were classified as non biofilm-forming and the remaining 27 (24.11%) as biofilm-forming. Using 
such scheme, the cut-off used for average OD492nm values was 0.83. 
4.2.3 Flow cell assay 
4.2.3.1 TSB1%glu flow assay 
The results of the flow system using TSB were equivalent to TCP results: both TCP negative strains 
produced no macroscopically visible biofilm while the two TCP positive strains formed a confluent 
growth along the slide surface. No clear difference between the two positives was observed.  
 
4.2.3.2 Raw milk flow assay 
While raw milk would provide even more realistic conditions, attempts to use raw milk collected 
with aseptic technique were unsuccessful in our system. The problems were attributed to the high 
milk fat content and contaminant bacteria.  
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4.2.3.3 UHT milk flow assay (MFC)  
Twelve biofilm-forming and 18 non biofilm-forming strains (n=30), with average ODs ranging 
from 0.17 to 2.56, were selected out of the 112 TCP tested strains. Out of these 30 field strains, 6 
(20%) formed biofilm in milk under flow conditions. Of these 6 MFC-positives, 4 where previously 
classified as non biofilm-forming by TCP. Also, both TCP positive and negative controls were not 
able to produce detectable (macro and microscopically) biofilms in the flow cell using milk as 
substrate.  
According to the kappa coefficient test, no agreement was found between the two methods with any 
apparent concordance being attributed to chance (kappa = -0.037). 
Sterility controls were run in all MFC experiments, plating aliquots from the inlet medium in 
bovine blood agar 5% (Oxoid, UK) Overall, apparent bacterial and/or fungal contamination could 
be observed. Also, all strains used were recovered in purity and in high concentrations from the 
outlet medium at the end of the 18h incubation period, independently of biofilm formation status.  
 
4.2.3.4 DNA Microarray characterization and correlation with biofilm formation on MFC.  
MFC-tested strains were assigned to 12 different clonal complexes (CC), according to microarray 
results. Strains classified as biofilm-forming by MFC grouped in CC479 (2 strains), or in CC705 (2 
strains), or in CC97, or in an undefined agrII/cap5 ST of animal origin. Out of 30 tested strains, the 
most frequent clonal complex was CC8 (11 strains), which included only MFC biofilm negatives 
and TCP-positives or -negatives.  
Microarray results showed genetic differences among MFC-tested strains, but only a limited 
number of genes (n= 14) was statistically related to strain ability to form biofilm in milk.  
A list of genes significantly related to MFC-positivity is summarized in table 2. The relative 
distribution of such genes among MFC-tested and MFC-positive strains are also reported.                                  
Only 1 out of 32 MFC-tested strains, did not carried the icaADBC operon (icaA, icaC and icaD 
genes). Such strain was used as TCP negative control and did not form biofilm in MFC.  
	  
	  
26	  
	  
Eight adhesion factors/MSCRAMMs (clfA, clfB, ebpS, eno, fnbA, map, sdrC and vwb) out of 15 
tested in the microarray were present in all MFC-tested strains. The remaining 7 factors (bbp, cna, 
ebh, fib, fnbB, sasG and sdrD) were distributed among the strains in 12 distinct profiles. No single 
adhesion/MSCRAMM or MSCRAMM profile was associated with biofilm formation in milk, since 
the 6 MFC positive strains showed 5 different profiles. 
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Table 2: Distribution and statistical significance of bacterial genes associated with biofilm production using the MFC method.
  
Distribution Significance 
Genes   
Overall 
(n=32) MFC-positive (n=6) (p-value<0.05) 
agrI type-I accessory gene regulator  16 (50%) 1 (16.67%) - 
agrII type-II accessory gene regulator  14 (48%) 5 (83.33%) 0.022 
agrIII type-III accessory gene regulator  1 (3.12%) none - 
agrIV type-IV accessory gene regulator  1 (3.12%) none - 
     cap5 capsular polysaccharide (CP) type 5 23 (71.9%) 2 (33.33%) - 
cap8 capsular polysaccharide (CP) type 8 9 (28.1%) 4 (66.66%) 0.024 
     bla β-lactamase operon (blaZ, blaI and blaR) 17 (53.13%) 1 (16.67%) 0.036 
fosB metallothiol transferase 21 (65.63%) 1 (16.67%) 0.006 
lmrP (RF122) multidrug transporter (efflux pump) 8 (25%) 4 (66.67%) 0.011 
lmrP (other than RF122) 
 
24 (75%) 2 (33.33%) - 
     lukM/lukF-PV (P-83) bicomponent leukocidin  7 (21.88%) 4 (66.67%) 0.004 
     sec enterotoxin C   (sec, sel and tst1) 2 (7%) 2 (33.33%) 0.003 
sel enterotoxin-like L 2 (7%) 2 (33.33%) 0.003 
tst1 toxic shock syndrome toxin 1 2 (7%) 2 (33.33%) 0.003 
ssl7 (absence) staphylococcal superantigen-like  protein 7 28 (87.5%) 2 (33.32%) 0.003 
ssl8 (absence) staphylococcal superantigen-like  protein 8 28 (87.5%) 3 (50%) 0.033 
ssl9 (absence) staphylococcal superantigen-like  protein 9 26 (81.25%) 2 (33.33%) 0,000 
     Q2FXC0 (absence) hypothetical protein, located next to serine protease operon 12 (37.5%) none 0.030 
Q7A4X2 hypothetical protein, located next to enterotoxin gene cluster (egc) 8 (25%) 5 (83.33%) 0.022 
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5 Discussion  
5.1 Biofilm characterization  
5.1.1 CRA 
Our first characterization of S. aureus isolates from bovine mastitis was carried out using the 
qualitative CRA method. Growth on CRA is reported in the literature as an easy to perform 
technique of good reproducibility, being indicated as a cost-effective screening test. Our 
preliminary results confirmed that the method is indeed reproducible, but important variations of 
phenotypes were observed among strains. Therefore, the results are not easily interpreted and the 
classification becomes a subjective task. Later on, it was clear that correlations between phenotype 
on CRA and the presence of ica locus or bap gene with TCP or MFC results were inexistent (data 
not shown), in accordance with some published studies (Knobloch et al., 2002, Rode et al., 2007). 
Even though not all isolates tested on CRA were tested also by the MFC method, at least two MFC 
positive isolates and one MFC negative shared the exact same appearance, displaying smooth/black 
colonies on CRA.      
            
5.1.2 TCP 
The TCP method was originally conceived to characterize the biofilm forming ability of S. 
epidermidis from human infections. Thereafter, S. epidermidis has been serving as a model to study 
biofilm formation in Staphylococci, although, this species differs greatly from S. aureus in the 
mechanisms used for biofilm formation (Rode et al., 2007). The classical setup of TCP method 
includes inoculation of a diluted bacterial suspension in TSB supplemented with glucose, since 
Staphylococci generally enhance matrix exopolysaccharide expression in the presence of increased 
concentrations of glucose (Götz, 2002). Glucose is a monosaccharide highly available in the host 
organism, particularly in blood. In the mammary gland compartment it is found mainly as part of 
the milk disaccharide lactose, and thus it is not readily available. The lack of correlation between 
TCP and  MFC results indicates that biofilm characterization in closed/static systems, especially 
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those applying  glucose medium, should not be used to draw general conclusions about the biofilm-
forming potential. 
During the standardization phase of TCP, some important technical and interpretative limitations of 
this method could be noted, which possibly affect its performance. The first issue regards how to 
selecte control strains, particularly the negative one. Fox, Zadoks and Gaskins (2005) used the ica-
defective S. epidermidis strain ATCC 12228 as the negative control strain to characterize S. aureus 
biofilms. This reference strain was also tested during our study and displayed an overall reduced 
growth, measured by broth turbidity and OD600nm after the incubation period (data not shown) when 
compared to S. aureus strains. We also had only access to non biofilm-forming S. aureus reference 
strains from human origin. For this reasons, we used one of our non biofilm-forming S. aureus field 
isolates, MB543, which is an ica-defective strain. The problem is that the average negative control 
OD492nm  is used in the cut-off point calculation following Christensen et al (1985). In this particular 
example, the measured OD492nm for S. aureus MB543 was 0.5 (SE = 0.11) against 0.27 (SD = 0.11) 
for S. epidermidis ATCC 12228, determining cut-off values of 0.83 and 0.57, respectively. As a 
consequence, the selection of controls itself represents a bias for the classification of strains as 
biofilm positive or negative.          
The differences in OD492nm values observed in the non-biofilm forming group raised some doubts 
about the biological relevance of the test. Statistically, the use of the negative control OD492nm plus 
three times the standard deviation (Christensen et al., 1985) it is absolutely reasonable. The curious 
fact is that the OD492nm values of non-biofilm forming strains do not converge around any overall 
similar value. Such observation would be expected, since similar concentrations were employed in 
the inocula and the final growth density of the majority of our strains is relatively uniform (data not 
shown). As observed by graph plotting, data of the non-biofilm forming strains are clearly 
continuous, similar to what observed in the biofilm-forming group. The variation between non 
biofilm-forming strains could be explained by diversely expressed adhesion factors among strains. 
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Each strain adhesin profile may promote different levels of adhesion of bacterial cells to the bottom 
of the well, even in the absence of matrix production.   
Another important issue is related to the concentration of the TCP inoculum. Some authors used 
1:100 (Melchior et al., 2009), while others used 1:40 dilution of overnight broth cultures of S. 
aureus (Cucarella et al., 2001, Vasudevan et al., 2003). We tested both dilutions using a reduced 
number of strains during the setup phase. Keeping unaltered other conditions like time of 
incubation, media and temperature, variations in the resulting OD492nm were observed for several, 
but not all strain tested (data not shown). The use of 1:40 dilution proved to be more reliable, 
resulting in more consistent OD492nm values between wells and plates, as verified by reduction of 
standard variation values. For this reason, we applied the 1:40 dilution factor. 
The washing step was also considered an important factor capable to significantly impact TCP 
results. While some authors wash away unbound bacteria without mentioning any particular 
concern (Vasudevan et al., 2003), others suggest that this step should be performed in very delicate 
manner (Cucarella et al., 2001, Melchior et al., 2009). In our experience, inadequate washing such 
applying the fluid with micropipettes directly over the bacterial pelicle or even at well walls, may 
produce “holes” and biofilm de-attachments. These procedures showed to easily remove not only 
unbound bacterial cells, but also clumps of matrix-embedded bacteria (as observed by light 
microscopy) giving incongruent results.           
 
5.1.3 MFC 
Few papers used milk as medium for S. aureus culture to characterize biofilm formation of mastitis 
isolates. Milk degradation by staphylococcal enzymes observed in the traditional TCP assay is 
linked to space limitation and static condition causing an artificial aggregation of milk residues to 
the matrix (Amorena et al., 1999). Enzymatic expression and activity can be highly variable among 
S. aureus strains, therefore the use of milk in static systems seems to provide only limited or 
unreliable information about the biofilm-forming ability of strains. Amorena et al. (1999) and 
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Melchior et al. (2007) used conventional media or skimmed UHT to establish biofilms of S. aureus 
mastitis isolates and noted striking differences in biofilm structure and functional characteristics.   
We used a dynamic method in order to avoid milk coagulation that occurs in closed systems. Milk 
is continuously produced inside the mammary gland; liquid flow is variable over time and is 
heterogeneous in the different gland compartments. Laminar milk flow is more likely to  occur in 
the upper parts of the mammary gland, characterized by ducts of smaller diameter, draining the milk 
just released inside the alveoli. Laminar flow was used in our system mainly to allow reproducible 
experimental conditions, since milk flow removes the excess of metabolites, unattached cells and  
supplies bacteria with fresh medium, provided by the continuously produced milk in the gland 
environment.      
Characteristics of milk flow inside the mammary gland, such as velocity and sense, are hard to 
investigate in vivo. Such information is mostly unknown and also expected to be variable among 
animals. We could not find in the literature studies regarding flow systems based on milk to study S. 
aureus biofilms. Therefore, time of adhesion and flow velocity were initially tested with settings 
from published papers, that used different systems, but showing at least some similarities with our 
conditions. Flow velocity was set at 30 mL/h according to Beenken, Melvins and Smeltzer (2003). 
The initial setting of 30 min for cell adhesion (Jaglic et al., 2011) was changed, after experimental 
tests, to 1 hour. This modification was made to provide a highly favorable environment to biofilm 
formation with more time to adhere. 
To ensure that the flow system would allow biofilm formation comparable to that observed in TCP 
assay, the flow system was initially tested using the same culture medium. Four control strains, 
previously tested by TCP, were selected for this purpose: two negatives, one positive and one 
strongly positive strain. The results obtained were similar to TCP results: both TCP negative strains 
produced no macroscopically visible biofilm under flow conditions, while the two TCP positive 
strains formed a confluent growth along the slide surface. 
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Later on, to better reproduce intra-mammary conditions, we tried to use aseptically collected raw 
milk with very low SCC counts (<1000/mL), as culture medium. Our attempts proved unsuccessful 
because of flow obstructions related to high fat content and unspecific TTC reduction by 
contaminant bacteria. Thereafter, skimmed UHT milk (<0.05% fat) was used, since it is a sterile 
alternative to raw milk and spray dried powdered milk.  
The small number of biofilm-forming strains in milk (n = 6, 20%) was an unexpected result, since 
37.5% of MFC-tested strains were considered biofilm-producers by the TCP assay. Overall, only 2 
strains were positive by both methods, while 4 MFC-positives were classified as TCP-negatives. 
Therefore, no statistical correlation could be found between the two methods. In the present study, a 
high and statistically determined cut-off value was used in order to identify the TCP strong positive 
strains. Even if the less severe and commonly used cut-off point were applied, no statistic 
association between static and dynamic system could be established (data not shown). These data 
strongly suggest that no useful information about the relation between biofilm formation and 
mastitis can be obtained from the standard characterization method using broth instead of milk.  
The array characterization assigned MFC-positive strains to CC705, CC479, CC97 and to an 
undefined agrII/caps 5 animal strain. Following Holmes and Zadoks (2011), CC705 is associated 
with the bovine host and CC479 and CC97 are among the most common genotypes associated with 
bovine mastitis across herds and countries. The prevalent group among MFC-tested strains was 
CC8 with 11 strains, none of these formed biofilm in milk. CC8 is one of the 10 major human 
lineages worldwide, but strains belonging to this group were also isolated from bovine mastitis, 
showing a lower degree of host-association.  
With the exception of two strains, those tested in MFC assay belonged either to agrI or to agrII 
allele types in similar proportion, but a clear preponderance of agrII strains (5/6) was observed 
among MFC positives, in accordance with the results of Melchior et al. (2009). A possible 
explanation could be that agrI strains better survive in the intracellular environment, while agrII 
strains evolved and adapted to the extracellular environment (Buzzola et al., 2007). Also, only one 
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penicillin-resistant strain was detected in the MFC-positive group. This finding confirms above 
considerations, since penicillin-resistance was reported as negatively correlated with agrII mastitis 
isolates (Melchior et al., 2009). 
Capsular polysaccharide (CP) serotypes 5 and 8 are reported as the most prevalent ones in bovine 
mastitis isolates. The proportion of each serotype is geographically variable and seems to be 
unrelated to any form of mastitis (Tollersrud et al., 2000). The 32 strains tested by MFC showed 
mainly capsular type 5, but a significant 66.6% of biofilm-positive strains was CP8. Both CP5 and 
CP8 mastitis strains are known to enhance capsular polysaccharide expression when grown in milk 
and in vivo (Sutra et al. 1990, Lee et al. 1993), but CP8 strains are less aggressive in a murine 
model and more sensitive to intracellular killing compared to CP5 strains (Watts et al., 2005).  
These characteristics could indicate that biofilm formation in mastitis is not related to intracellular 
survival, in accordance with agr findings.  
Statistical correlation was evidenced between carriage of leukocidin genes lukM/lukF-PV (P83) and 
biofilm formation in MFC, since 4 out of 6 MFC positive strains carried both subunits. Such 
bicomponent toxin is the most active leukotoxin against bovine neutrophils, but it is rarely found in 
human isolates (Rainard et al., 2003).  
Positivity in the dynamic system was also significantly associated with the LmrP multidrug 
transporter, but only with the RF122 homologous sequence. Interestingly, the 2 MFC-positive 
strains lacking lukM/lukF-PV harboured a different lmrP gene and were the only two showing CP5. 
It is important to note that statistical correlation was found only with RF122 and P83, which are 
bovine mastitis isolates, the former was the first whole sequenced strain, the latter was originally 
isolated from clinical mastitis (Kaneko et al., 1997, Fitzgerald et al., 2001). 
The significant correlation between biofilm formation under milk flow and absence of superantigen-
like proteins genes ssl7, ssl8 and ssl9 could not be biologically explained. Similarly, the function of 
the hypothetical proteins encoded by the sequences Q2FXC0 and Q7A4X2 is still not known, 
therefore the possible implication in biofilm production under MFC conditions is not clear. 
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Also, MSCRAMMs could not explain biofilm formation, neither as individual determinants nor in 
associations. Such result was expected, as a consequence of the natural variability and functional 
redundancy of MSCRAMMs in S. aureus strains (O’Riordan and Lee, 2004). 
   
5.2 Bap 
The large proportion of ica operon carriage among the MFC tested strains (96.88%) is in 
accordance with the literature (Vasudevan et al., 2003). The carriage of ica was not correlated with 
biofilm forming activity, either in TCP or in MFC assay. Interestingly, 9 strains were identified as 
ica positive only by microarray, being misidentified as ica negative by PCR. The inadequacy of 
primers could explain this difference found in our strains and also the great variance of ica carriage 
in other published articles that used PCR to inquiry the ica prevalence among S. aureus isolates 
(Arciola, Baldassari, Montanaro, 2001, Rhode et al., 2001). 
The low prevalence of bap recorded in the present study is in agreement with Cucarella et al. 
(2001). Also, all bap-positive S. aureus strains were from subclinical bovine mastitis and SCC were 
likely to be lower in milk samples harbouring those strains, in accordance with the limited literature 
on the subject (Cucarella et al., 2004).  
Differently from the first sampling, only bap-positive S. aureus were isolated in the second 
sampling in herd B. This replacement is probably due the low SCC promoted by bap-harboring 
strains, what delays mastitis detection. Cucarella et al. (2004) suggested that biofilm formation and 
long term tissue adhesion of bap-positive strains could determine persistent infections. In vitro 
observation showed that Bap is not expressed in medium with Calcium (Ca2+) concentrations 
similar to those found in milk (Arrizubieta et al., 2004) Therefore, the involvement of extracellular 
biofilm formation in the mammary gland could be ruled out. On the other hand, Bap could also be 
expressed in the intracellular environment. Biofilm components were shown to be expressed 
intracellularly, as it was demonstrated in experimental urinary tract infections caused by 
Escherichia coli (Anderson et al, 2003). Nevertheless, S. aureus use of such strategy, mediated by 
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Bap seems improbable, since eukaryotic cells contain high concentration of Ca2+ in intracellular 
stores (Arrizubieta et al., 2004). In addition, recent proteomic results showed that few proteins are 
up-regulated (around 10%) in in vitro intracellular S. aureus. Up-regulated proteins are mainly 
those associated with countermeasure systems against oxidative stress (Schmidt et al., 2010), which 
is not the case of the majority of biofilm-related proteins. Besides that, Bap was shown to 
negatively affect MSCRAMM activity (Cucarella et al., 2002), and at the same time reduces cell 
internalization through binding to host cell receptors (Valle et al., 2012).  
The results of the present study corroborate with the observations of Arrizubieta et al. (2004). None 
of our bap-positive strains (n = 3), which were all ica locus positive and strongly biofilm-positive 
by TCP,  was able to produce a detectable biofilm in milk under flow conditions. 
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6 Conclusion 
The biofilm forming ability of S. aureus strains from bovine mastitis showed different results when 
tested by the classical static assay, or by a dynamic system using milk as a culture medium. 
Therefore, S. aureus biofilm-forming potential of these strains should be critically evaluated and 
tested applying conditions similar to mammary environment. The strains sharing some of the genes 
most commonly detected in dairy cows isolates were more able to form biofilm in the dynamic 
system.  
From a pathogenetic point of view, the results of the present study could not give clear explanation 
of the role of the genes involved in biofilm formation with the establishment and/or development of 
dairy cow mastitis. While the longitudinal study, carried out in one herd with both bap-negative and 
bap-positive strains, showed a complete substitution of the first ones with the others, on the other 
hand no correlation was found between bap/icaAD and biofilm formation in the milk dynamic 
system. Therefore, further studies are necessary to determine whether the ability to form biofilm in 
MFC is correlated with increased virulence, facilitating the establishment of chronic infections in 
the mammary gland. Also, longitudinal studies in herds with bap-positive S. aureus strains will help 
understand their epidemiological behavior in dairy herds. While such strains are present both in 
Spanish and Italian herds in low prevalence, they seem well adapted to the bovine host and could 
potentially become the dominant strain inside a herd. 
 
Acknowledgements 
We thank Dr. José Penades (Centro Investigación y Tecnologia Animal, Instituto Valenciano de 
Investigaciones Agrarias, Segorbe, Spain; Universidad Cardenal Herrera-CEU, Moncada,  Spain) 
for kindly providing Staphylococcus aureus bap-positive strain V329. 
	  
	  
37	  
	  
7 References 
1. ALMEIDA, R. A., MATTHEWS, K. R., CIFRIAN E., GUIDRY A. J., OLIVER S. P. 
(1996). Staphylococcus aureus invasion of bovine mammary epithelial cells. Journal of 
Dairy Science, 79: 1021–1026. 
2. AMORENA, B., GRACIA, E., MONZÓN, M., LEIVA, J., OTEIZA, C., PÉREZ, M., 
ALABART, J.L., HERNÁNDEZ-YAGO, J. (1999). Antibiotic susceptibility assay for 
Staphylococcus aureus in biofilms developed in vitro. Journal of Antimicrobial 
Chemotherapy, 44: 43-55. 
3. ANDERSON, G. G., PALERMO, J.J., J. D. SCHILLING, J.D., R. ROTH, R., J. HEUSER, 
J., HULTGREN, S.J. (2003). Intracellular bacterial biofilm-like pods in urinary tract 
infections. Science, 301: 105-107. 
4. ARCIOLA, C.R., BALDASSARI, L., MONTANARO, L. (2001). Presence of icaA and 
icaD genes and slime production in a collection of Staphylococcal strains from catheter-
associated infections. Journal of Clinical Microbiology, 39(6): 2151-2156. 
5. ARCIOLA, C.R., CAMPOCCIA, D., GAMBERINI, S., CERVELLATI, M., DONATI, E., 
MONTANARO, L. (2002). Detection of slime production by means of an optimised Congo 
red agar plate test based on a colourimetric scale in Staphylococcus epidermidis clinical 
isolates genotyped for ica locus. Biomaterials, 23: 4233–4239. 
6. ARRIZUBIETA, M.J., TOLEDO-ARANA, A., AMORENA, B., PENADÉS, J.R., LASA, I. 
(2004). Calcium inhibits Bap-dependent multicellular behavior in Staphylococcus aureus. 
Journal of  Bacteriology, 186: 7490-7498. 
7. BEENKEN, K.E., BLEVINS, J.S., SMELTZER, M.S. (2003). Mutation of sarA in 
Staphylococcus aureus limits biofilm formation. Infection and Immunity, 71: 4206-4211. 
8. BOS, R., VAN DER MEI, H.C., MEINDERS, J.M., BUSSCHER, H.J. (1994). A 
quantitative method to study co-adhesion of microorganisms in a parallel plate flow 
chamber: basic principles of the analysis. Journal of Microbiological Methods, 20: 289-305. 
9. BOTREL, M.A., HAENNI, M., MORIGNAT, E., SULPICE, P. MADLEC, J.Y., 
CALAVAS, D. (2010). Distribution and antimicrobial resistance of clinical and sub clinical 
mastitis pathogens in dairy cows in Rhône-Alpes, France. Foodbourne Pathogens and 
Disease, 7(5): 479-87.   
10. BRAMLEY, A.J., CULLOR, J.S., ERSKINE, R.J., FOX, L.K., HARMON, R.J., HOGAN, 
J.S., NICKERSON, S.C., OLIVER, S.P., SMITH, K.L., SORDILLO, LM. (1996). 3 
Microorganisms that cause mastitis. In: Current Concepts of Bovine Mastitis, 4th ed. 
National Mastitis Council Inc., Madison, pp. 11-14. 
	  
	  
38	  
	  
11. BUZZOLA, F.R., ALVAREZ, L.P., TUCHSCHERR, L.P.N., BARBAGELATA, M.S., 
LATTAR, S.M., CALVINHO, L., SORDELLI, D.O. (2007). Differential abilities of 
capsulated and noncapsulated Staphylococcus aureus isolates from diverse agr groups to 
invade mammary epithelial cells. Infection and Immunity, 75: 886-891. 
12. CHRISTENSEN, G.D., SIMPSON, W.A., BISNO, A., BEACHY, E. (1982). Adherence of 
slime-producing strains of Staphylococcus epidermidis to smooth surfaces. Infection and 
Immunity, 37: 318–326. 
13. CHRISTENSEN, G.D., SIMPSON, W.A., YOUNGER, J.J., BADDOUR, L.M., BARRETT, 
F.F., MELTON, D.M., BEACHEY, E.H. (1985). Adherence of coagulase-negative 
staphylococci to plastic tissue culture plates: a quantitative model for the adherence of 
staphylococci to medical devices. Journal of Clinical Microbiology, 22: 996-1006. 
14. COENYE, T., NELIS, H.J. (2010). In vitro and in vivo model systems to study microbial 
biofilm formation. Journal of Microbiological Methods, 83: 89-105. 
15. COSTERTON, J.W. (2007). The Biofilm Primer (Springer series on biofilms). Springer-
Verlag, Berlin-Heidelberg, pp. 56-63. 
16. COSTERTON, J.W.; STEWART, P.S.; GREENBERG, E.P. (1999). Bacterial biofilms: a 
common cause of persistent infections. Science, 284: 1318-1322. 
17. CUCARELLA, C., SOLANO, C., VALLE, J., AMORENA, B., LASA, I., PENADÉS, J.R. 
(2001). Bap, a Staphylococcus aureus surface protein involved in biofilm formation. Journal 
of Bacteriology, 183(9): 2888-2896. 
18. CUCARELLA, C., TORMO, M.A., KNECHT, E., AMORENA, B., LASA, I., FOSTER, 
T.J., PENADES, J.R. (2002). Expression of the biofilm-associated protein interferes with 
host protein receptors of Staphylococcus aureus and alters the infective process. Infection 
and Immunity, 70(6): 3180-3186. 
19. CUCARELLA, C., TORMO, M.A., ÚBEDA, C., TROTONDA, M.P., MONZÓN, M. 
PERIS, C., LASA, I., PENADÉS, J.R. (2004). Role of biofilm-associated protein Bap in the 
pathogenesis of bovine Staphylococcus aureus. Infection and Immunity, 72(4): 2177-2185. 
20. DE LA FUENTE, R., BALLESTEROS, C., BAUTISTA, V., MEDINA, A., ORDEN, J.A., 
DOMÍNGUEZ-BERNAL, G., VINDEL, A. (2011). Staphylococcus aureus subsp. 
anaerobius isolates from different countries are clonal in nature. Veterinary Microbiology, 
150: 198-202.  
21. DE LA FUENTE, R., SUAREZ, G., SCHLEIFER, K. H. (1985). Staphylococcus aureus 
subsp. anaerobius subsp. nov., the causal agent of abscess disease of sheep. International 
Journal of Systematic and Evolutionary Microbiology, 35: 99–102. 
	  
	  
39	  
	  
22. DEGO, O.K., VAN DIJK, J.E., NEDERBRAGT, H. (2002) Factors involved in the early 
pathogenesis of bovine Staphylococcus aureus mastitis with emphasis on bacterial adhesion 
and invasion. A review. Veterinary Quarterly, 24: 181–198. 
23. DEIGHTHON, M., BORLAND, R., CAPSTICK, J.A. (1996). Virulence of Staphylococcus 
epidermidis in a mouse model: significance of extracellular slime. Epidemiology and 
Infection, 117: 267–280. 
24. DELGADO, S., GARCIA, P., FERNANDEZ, L., JIMENEZ, E., RODRIGUEZ-BANOS, 
M., DEL CAMPO, R., RODRÍGUEZ, J.M. (2011). Characterization of Staphylococcus 
aureus strains involved in human and bovine mastitis. FEMS Immunology and Medical 
Microbiology, 62(2): 225–235. 
25. DHANAWADE, N.B., KALOREY, D.R., SRINIVASAN, R., BARBUDDHE, S.B., 
KURKURE, N.V. (2009). Detection of intercellular adhesion genes and biofilm production 
in Staphylococcus aureus isolated from bovine subclinical mastitis. Veterinary Research 
Communications, 34: 81–89.  
26. DONLAN, R.M. (2011). Biofilm elimination on intravascular catheters: important 
considerations for the infectious disease practitioner. Clinical Infectious Diseases, 52: 1038–
1045. 
27. DRANCOURT, M., RAOULT, D. (2002). rpoB gene sequence-based identification of 
Staphylococcus species. Journal of Clinical Microbiology, 40: 1333-1338. 
28. FITZGERALD, J.R., MONDAY, S.R., FOSTER, T.J., BOHACH, G.A., HARTIGAN, P.J., 
MEANEY, W.J., SMYTH, C.J. (2001). Characterization of a putative pathogenicity island 
from bovine Staphylococcus aureus encoding multiple superantigens. Journal of 
Bacteriology, 183: 63-70. 
29. FLEMMING, H., WINGENDER, J. (2010). The biofilm matrix. Nature Reviews 
Microbiology,. 8: 623-633. 
30. FOSTER, T.J., AND HÖÖK, M. (1998) Surface protein adhesins of Staphylococcus aureus. 
Trends in Microbiology, 6: 484–488. 
31. FOX, L.K, ZADOKS, R.N., GASKINS, C.T. (2005). Biofilm production by Staphylococcus 
aureus associated with intramammary infection. Veterinary Microbiology, 107: 295–299.  
32. FREEMAN, D.J., FALKINER, F.R., KEANE, C.T. (1989). New method for detection slime 
production by coagulase negative staphylococci. Journal of Clinical Pathology, 42: 872–
874. 
33. GILL, S. R., FOUTS, D.E., ARCHER, G.L., MONGODIN, E.F., DEBOY, R.T., RAVEL, 
J., PAULSEN, I.T., KOLONAY, J.F., BRINKAC, L., BEANAN, M., DODSON, R.J., 
	  
	  
40	  
	  
DAUGHERTY, S.C., MADUPU, R., ANGIUOLI, V., DURKIN, A.S., HAFT, D.H., 
VAMATHEVAN, J., KHOURI, H., UTTERBACK, T., LEE, C., DIMITROV, G., JIANG, 
L., QIN, H., WEIDMAN, J., TRAN, K., KANG, K., HANCE, I.R., NELSON, K.E., 
FRASER, C.M. (2005). Insights on evolution of virulence and resistance from the complete 
genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a 
biofilm-producing methicillin-resistant Staphylococcus epidermidis strain. Journal of 
Bacteriology, 187: 2426-2438. 
34. GÖTZ, F. (2002). Staphylococcus and biofilms. Molecular Microbiology, 43: 1367-1378. 
35. GÖTZ, F., BANNERMAN, T., SCHLEIFER, K.H. (2006). Chapter 1.2.1 - The Genera 
Staphylococcus and Macrococcus. In: DWORKIN, M., FALKOW, S., ROSENBERG, E., 
SCHLEIFER, K.H.,  STACKEBRANDT, E. The Prokaryotes , 3rd ed. Berlin-Heidelberg: 
Springer-Verlag, vol. 4,  pp. 5–75. 
36. GROSS, M., CRAMTON, S.E., GÖTZ, F., PESCHEL, A. (2001). Key role of teichoic acid 
net charge in Staphylococcus aureus colonization of artificial surfaces. Infection and 
Immunity, 69: 3423–3426. 
37. GUDDING, R., MCDONALD, J.S., CHEVILLE, N.F. (1984). Pathogenesis of S. aureus 
mastitis: bacteriologic, histologic, and ultrastructural pathologic findings. American Journal 
of Veterinary Research, 45: 2525-2531. 
38. HAIR, J.F., ANDERSON, R.E., THATAM, R.L., BLACK, W.C. (2009). Cluster analysis. 
In: Multivariate Data Analysis. Prentice Hall, Englewood Cliffs, pp. 514-516. 
39. HALL-STOODLEY, L., STOODLEY P. (2009). Evolving concepts in biofilm infections. 
Cellular Microbiology, 11: 1034–1043. 
40. HÉBERT, A., SAYASITH, K., SENESCHAL, S., DUBREUIL, P., LAGACÉ, J. (2000). 
Demonstration of intracellular Staphylococcus aureus in bovine mastitis alveolar cells and 
macrophages isolated from naturally infected cow milk. FEMS Microbiology Letters, 193: 
57-62. 
41. HENSEN, S. M., PAVICIC, M.J., LOHUIS, J.A.,DE HOOG, J.A., B. POUTREL, B. 
(2000). Location of Staphylococcus aureus within the experimentally infected bovine udder 
and the expression of capsular polysaccharide type 5 in situ. Journal of Dairy Science, 83: 
1966-1975. 
42. HERMANS, K., DEVRIESE, L.A., HAESENBROUCK, F. (2010). 5. Staphylococcus. p. 
75-85. In: GYLES, C.L.; PRESCOTT, J.F.; SONGER, G.; THOEN, C.O. Pathogenesis of 
bacterial infections in animals, 4th ed. Ames: Wiley-Blackwell.  
	  
	  
41	  
	  
43. HOGAN, J.S., GONZALES, R.N., HARMON, R.J., NICKERSON, S.C., OLIVER, S.P., 
PANKEY, J.W., SMITH, K.L. (1999). Laboratory Handbook on Bovine Mastitis, revised 
edition. National Mastitis Council Inc., Madison, pp. 5-11, 71-73. 
44. HØIBY, N.; BJARNSHOLT, T.; GIVSKOV, M.; MOLIN, S.; CIOFU, O. (2010). 
Antibiotic resistance of bacterial biofilms. International Journal of Antimicrobial Agents, 
35: 322-332. 
45. HOLMES, M.A., ZADOKS, R.N. (2011). Methicillin resistant S. aureus in human and 
bovine mastitis. Journal of Mammary Gland Biology and Neoplasia, 16: 373-382. 
46. IKAWATI, R., BROUWER, E.C., VAN DUIJKEREN, E., MEVIUS, D., VERHOEF, J., 
FLUIT, A.C. (2010) Virulence factors of genotyped bovine mastitis Staphylococcus aureus 
isolates in the Netherlands. International Journal of Dairy Science, 5(2): 60-70. 
47. International Dairy Federation (IDF), (2006) Staphylococcus aureus intramammary 
infections, Bulletin no.408. International Dairy Federation, Brussels, Belgium.  
48. IZANO, E.A., AMARANTE, M.A., KHER, W.B., KAPLAN, J.B. (2008). Differential roles 
of poly-N-acetylglucosamine surface polysaccharide and extracellular DNA in 
Staphylococcus aureus and Staphylococcus epidermidis biofilms. Applied and 
Environmental Microbiology, 74: 470-476. 
49. JAGLIC, Z., CERVINKOVA, D., MICHU, E., HOLASOVA, M., ROUBAL, P., VLKOVA, 
H., BABAK, V., SCHLEGELOVA, J. (2011). Effect of milk temperature and flow on the 
adherence of Staphylococcus epidermidis to stainless steel in amounts capable of biofilm 
formation. Dairy Science and Technology, 91: 361-372. 
50. KANEKO, J., MURAMOTO, K., KAMIO, Y. (1997). Gene of LukF-PV-like component of 
Panton-Valentine leukocidin in Staphylococcus aureus P83 is linked with lukM. Bioscience, 
Biotechnology, and Biochemistry, 61: 541-544. 
51. KENNEDY, C.A., O'GARA, J.P. (2004). Contribution of culture media and chemical 
properties of polystyrene tissue culture plates to biofilm development by Staphylococcus 
aureus. Journal of Medical Microbiology, 53: 1171-1173. 
52. KNOBLOCH, J.K., HORSTKOTTE, M.A., ROHDE, H., MACK, D. (2002). Evaluation of 
different detection methods of biofilm formation in Staphylococcus aureus. Medical 
Microbiology and Immunology, 191: 101–106. 
53. LASA, I., PENADES, J.R. (2006). Bap: A family of surface proteins involved in biofilm 
formation. Research in Microbiology, 157: 99–107. 
	  
	  
42	  
	  
54. LAUDERDALE, K.J., BOLES, B.R., CHEUNG, A.L., HORSWILL, A.R. (2009). 
Interconnections between Sigma B, agr, and proteolytic activity in Staphylococcus aureus 
biofilm maturation. Infection and Immunity, 77: 1623–1635. 
55. LEE, J.C., TAKEDA, S., LIVOLSI, P.J., PAOLETTI, L.C. (1993). Effects of in vitro and in 
vivo growth conditions on expression of type-8 capsular polysaccharide by Staphylococcus 
aureus. Infection and Immunity, 61: 1853-1858. 
56. MADIGAN, M.T., MARTINKO, J.M., DUNLAP, P.V., CLARK, D.P. 2009. Food 
poisoning and food borne diseases – Staphylococcal food poisoning. In: Brock, Biology of 
microorganisms (12th Edition). Pearson-Benjamin Cummings, San Francisco, pp. 1051-
1052. 
57. MALACHOWA N., DELEO F. R. (2010). Mobile genetic elements of Staphylococcus 
aureus. Cellular and Molecular Life Sciences. 67: 3057–3071. 
58. MELCHIOR, M. B., VAN OSCHA, M.H.J., GRAATA, R.M., VAN DUIJKERENB, E., 
MEVIUSC, D.J., NIELEND, M., GAASTRAB, W., FINK-GREMMELS, J. (2009). Biofilm 
formation and genotyping of Staphylococcus aureus bovine mastitis isolates: evidence for 
lack of penicillin-resistance in agr-type II strains. Veterinary Microbiology, 137: 83-89. 
59. MELCHIOR, M.B., FINK-GREMMELS, J., GAASTRA, W. (2007). Extended 
antimicrobial susceptibility assay for Staphylococcus aureus isolates from bovine mastitis 
growing in biofilms. Veterinary Microbiology, 125: 141-149. 
60. MELCHIOR, M.B., VAARKAMP, H., FINK-GREMMELS, J. (2006). Biofilms: A role in 
recurrent mastitis infections? Veterinary Journal, 171: 398-407. 
61. OLIVEIRA, M., BEXIGA, R., NUNES, S. F., VILELA, C. L. (2011). Invasive potential of 
biofilm-forming staphylococci bovine subclinical mastitis isolates. Journal of Veterinary 
Science, 12: 95–97. 
62. OLIVEIRA, M., BEXIGA, R., NUNES, S.F., CARNEIRO, C., CAVACO, L.M., 
BERNARDO, F., VILELA, C.L. (2006). Biofilm-forming ability profiling of 
Staphylococcus aureus and Staphylococcus epidermidis mastitis isolates. Veterinary 
Microbiology, 118: 133-140. 
63. O'NEILL, E., POZZI, C., HOUSTON, P., HUMPHREYS, H., ROBINSON,  D.A., 
LOUGHMAN, A., FOSTER, T.J., O'GARA, J.P. (2008). A novel Staphylococcus aureus 
biofilm phenotype mediated by the fibronectin-binding proteins, FnBPA and FnBPB. 
Journal of Bacteriology, 190: 3835-3850. 
64. O'RIORDAN, K., LEE, J.C. (2004). Staphylococcus aureus capsular polysaccharides. 
Clinical Microbiology Reviews, 17: 218-234. 
	  
	  
43	  
	  
65. OTTO, M. (2008). Staphylococcal biofilms. Current Topics in Microbiology and 
Immunology, 322: 207–228. 
66. PALMER, R.J., HAAGENSEN, J., NEU, T.R., STERNBERG, C. (2006). Confocal 
microscopy of biofilms – spatiotemporal approaches. In: Pawley, J.B. (Ed.), Handbook of 
Biological Confocal Microscopy, Springer, New York, pp. 882–900. 
67. PARSEK, M.R., SINGH, P.K. (2003). Bacterial biofilms: an emerging link to disease 
pathogenesis. Annual Review of Microbiology, 57: 677-701. 
68. PHILPOT W. N., NICKERSON S. C. (1991). 2 Mastitis – Why should I be concerned? In: 
Mastitis: counterattack. Babson Bros. Co, Naperville, pp 8-11. 
69. PICCININI, R., BORROMEO, V., ZECCONI, A. (2010). Relationship between S.aureus 
gene pattern and dairy herd mastitis prevalence. Veterinary Microbiology, 145: 100-5.   
70. PICCININI, R., TASSI, R., DAPRÀ, V., PILLA, R., FENNER, J., CARTER, B., M.F. 
ANJUM, M.F. (2012). Study of Staphylococcus aureus collected at slaughter from dairy 
cows with chronic mastitis. Journal of Dairy Research, 79: 249–255. 
71. PILLA, R., SNEL, G.G.M., MALVISI, M., PICCININI, R. (2012). Duplex real-time PCR 
assay for rapid identification of Staphylococcus aureus isolates from dairy cow milk. 
Journal of Dairy Research, 80: 223-226. 
72. RACHID, S., OHLSEN, K., WALLNER, U., HACKER, J., HECKER, M., AND 
ZIEBUHR, W. (2000). Alternative transcription factor sigma B is involved in regulation of 
biofilm expression in a Staphylococcus aureus mucosal isolate. Journal of Bacteriology, 
182: 6824–6826. 
73. RAINARD, P., CORRALES, J.C., BARRIO, M.B., COCHARD, T., POUTREL, B. (2003). 
Leucotoxic activities of Staphylococcus aureus strains isolated from cows, ewes, and goats 
with mastitis: importance of LukM/LukF'-PV leukotoxin. Clinical and Diagnostic 
Laboratory Immunology, 10: 272-277. 
74. RODE, T. M., LANGSRUD, S., HOLCK, A., MØRETRØ, T. (2007). Different patterns of 
biofilm formation in Staphylococcus aureus under food-related stress conditions. 
International Journal of Food Microbiology, 116: 372–383. 
75. ROHDE, H., KNOBLOCH, J.K.M., HORSTKOTTE, M.A., MACK, D. (2001). Correlation 
of Staphylococcus aureus icaADBC genotype and biofilm expression phenotype. Journal of 
Clinical Microbiology, 39(12): 4595-4596. 
76. RUPP, C.J., FUX, C.A., STOODLEY, P. (2005). Viscoelasticity of Staphylococcus aureus 
biofilms in response to fluid shear allows resistance to detachment and facilitates rolling 
migration. Applied and Environmental Microbiology, 71: 2175–2178. 
	  
	  
44	  
	  
77. SCHLOTTER, K., EHRICHT, R., HOTZEL, H., MONECKE, S., PFEFFER, M., DONAT, 
K. (2012). Leukocidin genes lukF-P83 and lukM are associated with Staphylococcus aureus 
clonal complexes 151, 479 and 133 isolated from bovine udder infections in Thuringia, 
Germany. Veterinary Research, 43:42. 
78. SCHMIDT, F., SCHARF, S.S., HILDEBRANDT, P., BURIAN, M., BERNHARDT, J., 
DHOPLE, V., KALINKA, J., GUTJAHR, M., HAMMER, E., VÖLKER, U. (2010). Time-
resolved quantitative proteome profiling of host-pathogen interactions: The response of 
Staphylococcus aureus RN1HG to internalisation by human airway epithelial cells. 
Proteomics, 10: 2801–2811. 
79. SCHRODER, A.C., HAMANN, J. (2005). The influence of technical factors on differential 
cell count in milk. Journal of Dairy Research, 72: 153–158. 
80. SMITH, E.J., VISAI, L., KERRIGAN, S.W., SPEZIALE, P., FOSTER, T.J. (2011) The Sbi 
protein is a multifunctional immune evasion factor of Staphylococcus aureus. Infection and 
Immunity 79: 3801–3809. 
81. SUTRA, L., RAINARD, P., POUTREL, B. (1990). Phagocytosis of mastitis isolates of 
Staphylococcus aureus and expression of type 5 capsular polysaccharide are influenced by 
growth in the presence of milk. Journal of Clinical Microbiology, 28: 2253-2258. 
82. TOLLERSRUD, T., KENNY, K., REITZ, A.J., LEE, J.C. (2000). Genetic and serologic 
evaluation of capsule production by bovine mammary isolates of Staphylococcus aureus and 
other Staphylococcus spp. from Europe and the United States. Journal of Clinical 
Microbiology, 38: 2998-3003. 
83. TORMO, M.A., KNECHT, E., GOTZ, F., LASA, I., PENADES, J.R. (2005) Bap-dependent 
biofilm formation by pathogenic species of Staphylococcus: evidence of horizontal gene 
transfer? Microbiology, 151: 2465–2475. 
84. VALLE J., LATASA C., GIL C., TOLEDO-ARANA A., SOLANO C., PENADÉS J. R., 
LASA I. (2012). Bap, a biofilm matrix protein of Staphylococcus aureus prevents cellular 
internalization through binding to GP96 host receptor. PLoS Pathog, 8: e1002843. 
85. VASUDEVAN, P., NAIR, M.K.M., ANNAMALAI, T., VENKITANARAYANAN, K.S. 
(2003). Phenotypic and genotypic characterization of bovine mastitis isolates of 
Staphylococcus aureus for biofilm formation. Veterinary Microbiology, 92: 179–185. 
86. VAUTOR, E., ABADIE, G., PONT, A., THIERY, R. (2008). Evaluation of the presence of 
the bap gene in Staphylococcus aureus isolates recovered from human and animal especies. 
Veterinary Microbiology, 127(3-4): 407-411. 
	  
	  
45	  
	  
87. VINOGRADOV, E., SADOVSKAYA, I., LI, J., JABBOURI, S. (2006). Structural 
elucidation of the extracellular and cell-wall teichoic acids of Staphylococcus aureus 
MN8m, a biofilm forming strain. Carbohydrate Research, 341: 738-743. 
88. VUONG, C., SAENZ, H.L., GÖTZ, F., AND OTTO, M. (2000). Impact of the agr quorum-
sensing system on adherence to polystyrene in Staphylococcus aureus. The Journal of 
Infectious Diseases, 182: 1688–1693. 
89. WATTS, A., KE, D., WANG, Q., PILLAY, A., NICHOLSON-WELLER, A., LEE, J.C. 
(2005). Staphylococcus aureus strains that express serotype 5 or serotype 8 capsular 
polysaccharides differ in virulence. Infection and Immunity, 73: 3502-3511. 
90. WIELAND, B., FEIL, C., GLORIA-MAERKER, E., THUMM, G., LECHNER, M., 
BRAVO, J.M., PORALLA, K., GÖTZ, F. (1994). Genetic and biochemical analyses of the 
biosynthesis of the yellow carotenoid 4,4′-diaponeurosporene of Staphylococcus aureus. 
Journal of Bacteriology, 176: 7719–7726. 
	  
	  
46	  
	  
 
  Species marker 39 kdpD-SCC 76 tet(K) 
1 rrnD1 (S. aureus) 40 kdpE-SCC 77 tet(M) 
2 gapA 41 mecI 78 cat (total) 
3 katA 42 mecR 79 cat (pC221) 
4 coA 43 xylR 80 cat (pc223) 
5 nuc1 44 ccrA-3 81 cat (pMC524/pC194 ) 
6 spa  45 ccrB-3 82 cat (pSBK203R) 
7 sbi 46 merA 83 cfr 
  Regulatory genes 47 merB 84 fexA 
8 sarA 48 ccrAA (MRSAZH47)_probe 1 85 fosB 
9 saeS 49 ccrAA (MRSAZH47)_probe 2 86 fosB (plasmid) 
10 vraS 50 ccrC (85-2082)   Resistance: Efflux systems 
11 agrI (total) 51 ccrA-4 87 qacA 
12 agrB-I 52 ccrB-4 88 qacC (total) 
13 agrC-I   Penicillinase 89 qacC (consensus) 
14 agrD-I 53 blaZ 90 qacC (equine) 
15 agrII (total) 54 blaI 91 qacC (SA5) 
16 agrB-II 55 blaR 92 qacC (Ssap) 
17 agrC-II   Resistance: MLS-Antibiotics 93 qacC (ST94) 
18 agrD-II 56 erm(A) 94 sdrM  
19 agrIII (total) 57 erm(B)   Resistance: Glycopeptides 
20 agrB-III 58 erm(C) 95 vanA 
21 agrC-III 59 lnu(A) 96 vanB 
22 agrD-III 60 msr(A) 97 vanZ 
23 agrIV (total) 61 mef(A)   Toxic shock syndrome toxin 
24 agrB-IV 62 mph(C) 98 tst1 (consensus) 
25 agrC-IV 63 vat(A) 99 tst1 ("human" allele) 
26 hld 64 vat(B) 100 tst1 ("bovine" allele) 
  Methicillin resistance and 65 vga(A)   Enterotoxins 
  SCCmec typing 66 vga(A) (BM 3327) 101 sea 
27 mecA 67 vgB(A) 102 sea (320E)  
28 delta_mecR   Resistance:  Aminoglycosides 103 sea (N315)/sep 
29 ugpQ 68 aacA-aphD 104 seb 
30 ccrA-1 69 aadD 105 sec 
31 ccrB-1 70 aphA3 106 sed 
32 plsSCC (COL)   Resistance: Miscellaneous  107 see 
33 Q9XB68-dcs   genes 108 seg 
34 ccrA-2 71 sat 109 seh 
35 ccrB-2 72 dfrS1 110 sei 
36 kdpA-SCC 73 far1 111 sej 
37 kdpB-SCC 74 fusC (Q6GD50) 112 sek 
38 kdpC-SCC 75 mupA 113 sel 
Supplementary table 1: list of 329 gene/sequence probes in the Allere microarray chip 
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114 selm   Epithelial differentiation  188 ssl05/set3_probe 2 (612) 
115 seln (consensus)   inihibitor 189 ssl05/set3 (MRSA252) 
116 seln (other than RF122) 151 edinA 190 ssl06/set21 
117 selo 152 edinB 191 ssl06 (NCTC8325+MW2) 
118 egc (total) 153 edinC 192 ssl07/set1 
119 seq   ACME locus 193 ssl07/set1 (MRSA252) 
120 ser 154 ACME (total) 194 ssl07/set1 (AF188836) 
121 selu 155 arcA-SCC 195 ssl08/set12_probe 1 
122 ORF CM14_ probe1 156 arcB-SCC 196 ssl08/set12_probe 2 
123 ORF CM14_ probe2 157 arcC-SCC 197 ssl09/set5_probe 1 
  hlg and leukocidins 158 arcD-SCC 198 ssl09/set5_probe 2 
124 lukF   Proteases 199 ssl09/set5 (MRSA252) 
125 lukS 159 aur (consensus) 200 ssl10/set4 
126 lukS (ST22+ST45) 160 aur (other than MRSA252) 201 ssl10 (RF122) 
127 hlgA 161 aur (MRSA252) 202 ssl10/set4 (MRSA252) 
128 lukF-PV 162 splA 203 ssl11/set2 (COL) 
129 lukS-PV 163 splB 204 ssl11+set2(Mu50+N315) 
130 lukF-PV (P83) 164 splE 205 ssl11+set2(MW2+MSSA476) 
131 lukM 165 sspA 206 ssl11/set2 (MRSA252) 
132 lukD   Superantigen/Enterotoxin-like 207 setB3 
133 lukE 166 setC 208 setB3 (MRSA252) 
134 lukX 167 ssl01/set6_probe1_11 209 setB2 
135 lukY  168 ssl01/set6_probe2_11 210 setB2 (MRSA252) 
136 lukY (ST30+ST45) 169 ssl01/set6_probe1_12 211 setB1 
  Haemolysins 170 ssl01/set6_probe2_12    Capsule and biofilm genes 
137 hl 171 ssl01/set6_probe4_11 212 cap 1 (total) 
138 hla 172 ssl01/set6_probeRF122 213 capH1 
139 hlIII (consensus) 173 ssl01/set6 (COL) 214 capJ1 
140 hlIII (other than RF122) 174 ssl01/set6 (Mu50+N315) 215 capK1 
141 hlb_probe 1 175 ssl01/set6 (MW2+MSSA476) 216 cap 5 (total) 
142 hlb_probe 2 176 ssl01/set6 (MRSA252) 217 capH5 
143 hlb_probe 3 177 ssl01/set6 (RF122) 218 capJ5 
144 un-disrupted hlb 178 ssl01/set6 (other alleles) 219 capK5 
  hlb-conversion phages 179 ssl02/set7 220 cap 8 (total) 
145 sak 180 ssl02/set7 (MRSA252) 221 capH8 
146 chp 181 ssl03/set8_probe 1 222 capI8 
147 scn 182 ssl03/set8_probe 2 223 capJ8 
  Exfoliative toxins 183 ssl03/set8 (MRSA252, SAR424) 224 capK8 
148 etA 184 ssl04/set9 225 icaA 
149 etB 185 ssl04/set9 (MRSA252, SAR425) 226 icaC 
150 etD 186 ssl05/set3_probe 1 227 icaD 
    187 ssl05/set3 (RF122, probe-611) 228 bap 
Supplementary table 1: (cont.) 
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  Adhesion factors (MSCRAMM) 270 map (COL) 303 lmrP (other than  
229 bbp (total) 271 map (MRSA252)   RF122)_probe2 
230 bbp (consensus) 272 map (Mu50+MW2) 304 lmrP (RF122)_probe1 
231 bbp (COL+MW2) 273 sasG (total) 305 lmrP (RF122)_probe2 
232 bbp (MRSA252) 274 sasG (COL+Mu50)   Type I restriction/modification 
233 bbp (Mu50) 275 sasG (MW2)   system, single sequence  
234 bbp (RF122) 276 sasG (other than    specificity protein 
235 bbp (ST45)   MRSA252+RF122) 306 hsdS1 (RF122) 
236 clfA (total) 277 sdrC (total) 307 hsdS2 (Mu50+N315+COL+ 
237 clfA (consensus) 278 sdrC (consensus)   USA300+NCTC8325) 
238 clfA (COL+RF122) 279 sdrC (B1) 308 hsdS2 (MW2+MSSA476) 
239 clfA (MRSA252) 280 sdrC (COL) 309 hsdS2 (RF122) 
240 clfA (Mu50+MW2) 281 sdrC (Mu50) 310 hsdS2 (MRSA252) 
241 clfB (total) 282 sdrC  311 hsdS3 (all other than RF122+  
242 clfB (consensus)   (MW2+MRSA252+RF122)   MRSA252) 
243 clfB (COL+Mu50) 283 sdrC (other than  312 hsdS3 (COL+USA300+NCTC 
244 clfB (MW2)   MRSA252+RF122)   8325+MW2+MSSA476+RF122) 
245 clfB (RF122) 284 sdrD (total) 313 hsdS3 (Mu50+N315) 
246 cna 285 sdrD (consensus) 314 hsdS3 (CC51+ MRSA252) 
247 ebh (consensus) 286 sdrD (COL+MW2) 315 hsdS3 (MRSA252) 
248 ebpS (total) 287 sdrD (Mu50) 316 hsdSx (CC25) 
249 ebpS_probe 612 288 sdrD (other) 317 hsdSx (CC15) 
250 ebpS_probe 614 289 vwb (total) 318 hsdSx (etd) 
251 ebpS (01-1111) 290 vwb (consensus)   Miscelaneous genes 
252 ebpS (COL) 291 vwb (COL+MW2) 319 Q2FXC0 
253 eno 292 vwb (MRSA252) 320 Q2YUB3 
254 fib 293 vwb (Mu50) 321 Q7A4X2 
255 fib (MRSA252) 294 vwb (RF122)   Hyaluronate lyase 
256 fnbA (total)   Immunodominant Ag B 322 hysA1 (MRSA252) 
257 fnbA (consensus) 295 isaB 323 hysA1 (MRSA252+RF122)  
258 fnbA (COL) 296 isaB (MRSA252)   and/or hysA2 (consensus) 
259 fnbA (MRSA252)   Defensin resistance 324 hysA1 (MRSA252+RF122)  
260 fnbA (Mu50+MW2) 297 mprF (COL+MW2)   and/or hysA2 (COL+USA300) 
261 fnbA (RF122) 298 mprF (Mu50+MRSA252) 325 hysA2 (all other than  
262 fnbB (total)   Transferrin binding protein   MRSA252) 
263 fnbB (COL) 299 isdA (consensus) 326 hysA2 (COL+USA300+ 
264 fnbB (COL+Mu50+MW2) 300 isdA (MRSA252)   NCTC8325) 
265 fnbB (Mu50) 301 isdA (other than MRSA252 ) 327 hysA2 (all other than  
266 fnbB (MW2)   Putative transporter   COL+USA300+NCTC8325) 
267 fnbB (ST15) 302 lmrP (other than  328 hysA2 (all other than  
268 fnbB (ST45-2)   RF122)_probe1   COL+USA300+NCTC8325) 
269 map (total)     329 hysA2 (MRSA252) 
Supplementary table 1: (cont.) 
